Investors abandoned equities as concerns grew that high data center expenses and tighter financing are stalling the tech investment boom. The downturn was exacerbated by steep losses in major chipmakers, including a sharp single-day decline for Nvidia Corp. amid regulatory scrutiny. Spillover volatility also impacted emerging markets and Bitcoin while shifting expectations around near-term central bank monetary policy. Although pressures from inflation and rates persist, analysts observe that corrections of this severity historically do not typically transition into full bear markets.
Key points
Growing skepticism over the speed and profitability of artificial intelligence buildouts…: Growing skepticism over the speed and profitability of artificial intelligence buildouts is driving a fundamental repricing of technology assets.
Rapidly spreading market volatility across diverse asset classes caused traders to reduce…: Rapidly spreading market volatility across diverse asset classes caused traders to reduce bets on a December Federal Reserve interest rate hike.
Historical data indicates that market corrections of this size generally do not evolve in…: Historical data indicates that market corrections of this size generally do not evolve into protracted bear markets despite ongoing inflation pressures.
Sources checked by our analysis pipeline: 1
US stocks took a beating amid fears surrounding artificial intelligence and technology stocks, Bloomberg reported today.
Anxiety around viability of AI projects, triggered a full-blown selloff, pushing the Nasdaq 500 to its lowest since the COVID-19 pandemic and the S&P 500 into correction mode.
Investors rushed to the safety of bonds and haven currencies amid fears that Wall Street’s biggest investment boom in decades is running out of steam.
The S&P 500 equity benchmark down 3.7%, with the index falling for a seventh straight day. The Nasdaq 100 lost 5.6% Friday, posting its worst week since March 2020. Nvidia Corp. sank 14% as Reuters reported US regulators are investigating its accounting practices. Anthropic PBC erased a portion of its first-day surge. A gauge of chipmakers sank 11%.
“Smackdown!” said Steve Sosnick at Interactive Brokers. “The problem stems from investors’ rapidly changed perceptions about technology, particularly the pace and cost of the artificial-intelligence buildout.”
The resurgence in equity volatility sent the so-called fear gauge to its highest since April 2025. Those jitters rippled around the globe, engulfing metals, Bitcoin and emerging…
Emerging from years of frustration with international credit evaluations, the newly established continental bureau seeks to alleviate steep borrowing costs that penalize non-defaulting governments. Operating from Mauritius, the institution plans to release its first sovereign evaluations in early 2024 to better capture local economic realities. Its eventual market influence hinges on providing objective risk analysis that global investors can trust despite skepticism from established rating firms.
Global pharmaceutical innovators are increasingly transferring production and research contracts to Indian developers to establish resilient supply chains and trim operational expenses. Despite uneven earnings across the wider pharmaceutical market, specialized manufacturers are capturing market share by shifting capabilities toward high-value intermediates, complex custom synthesis, and peptides. This operational pivot has shielded select suppliers from broader industry volatility and accelerated their top-line e…
UBS has highlighted a resilient investment case for commodities, even as the oil supply premium eases. The bank maintains this outlook despite the shifting dynamics in the oil market.